Facebook
X
LinkedIn
Forward13th Annual Sickle Cell Conference
The 13th Annual Sickle Cell Disease conference is a collaboration between the Duke University School of Nursing and the University of North Carolina at Chapel Hill, School of Medicine Blood Research Center. The 13th Annual Sickle Cell Disease Conference will be two-day, hybrid conference that will focus on thriving with sickle cell disease across the life span. Day 1 will provide updates on SCD therapies, transition for pediatric to adult care, and providing care for older adults with SCD. These sessions will address health and psychosocial needs and provide a testimony from a person with SCD. Day 2 will focus on managing SCD, SCD advocacy in the clinical setting and community, and will include a working group to identify the clinical care, research and legislative priorities for SCD in NC. The target audience for the conference include researcher and clinicians, including hematologists, primary care physicians, nurse practitioners, physical assistants, public health professionals, people with sickle cell disease and their families, community-based organization, students and trainees.
Target Audience
Fellows
Medical Students
Nurses
Nurse Practitioners
Physicians
Physician Assistants
Residents
Learning Objectives
Describing current and emerging treatments for sickle cell disease.
Evaluating the clinical implications of new therapies for patient care.
Identifying the health challenges faced by older adult with SCD.
Identifying the psychosocial challenges faced by older adult with SCD.
Incorporating patient perspectives to improve care of the older adult with SCD
Identifying the health challenges faced by youth with SCD during the transition phase.
Identifying the psychosocial challenges faced by youth with SCD during the transition phase.
Incorporating patient perspectives to improve transition outcomes.
Summarizing key takeaways from day 1 sessions.
Identifying effective symptom management and supportive care strategies.
Enhancing effective communication of healthcare needs to providers.
Understanding barriers to medication access and how to navigate them.
Recognizing the role of community-based organizations in supporting SCD care.
Gaining awareness of current state-level initiatives for SCD.
Learning how to engage with legislators and advocate for health policy changes.
Participating in group discussions to identify key priorities for NC and develop actionable steps for advancing SCD care and advocacy.
Jane Little
JJ Strouse, MD
Samuel Wilson, MD
Shenika Richardson
Justina Williams, MSW
Julie Rose
Katie Lipe
Elazzoa McArthur
Sheh-Li Chen, PharmD, BCOP
Melisssa Gordon-Pitts, LCSW, ACM-SW
Langston Harrison
Vernonica Mathis
Eberechi Nwogu-Onyemkpa, MD
Mofi Obadina, MD
Tiffany Bell, MSW
Charity Oyedeji, MD
AMA PRA Category 1 Credit(s)
ANCC
IACET CEU
JA Credit - AH
Available Credit
- 9.50 AMA PRA Category 1 Credit(s)™
- 9.50 ANCC
- 9.50 Attendance
- 0.95 IACET CEU
- 9.50 JA Credit - AH